Multiple topics were discussed at Wednesday’s State of The IVD Industry Webinar. Tariffs. NIH cuts. Proposed Medicaid changes. Agency shakeups. The FDA LDT ruled unlawful by a court. At the same time: new IVD products, emerging infectious threats, and breakthrough technologies hitting the market.
Watch the webinar here:
